BioStem Technologies, listed under OTCMKTS:BSEM, announced its earnings results on March 14, 2024. The company reported an earnings per share (EPS) of $0.03 for the quarter, according to Zacks Investment Research. Following this announcement, shares of BioStem Technologies fell by 11%, trading down by $0.51 to reach $4.14 during midday trading.
Trading volume for BioStem Technologies reached 81,179 shares, surpassing its average volume of 66,462. The company’s market capitalization stands at approximately $69.43 million, with a price-to-earnings ratio of 3.63 and a beta of -0.44.
Investors may note the company’s performance over recent months, as it has a 50-day simple moving average of $4.93 and a two-hundred day simple moving average of $9.21. Over the past year, BioStem Technologies has experienced significant fluctuations, with a twelve-month low of $3.38 and a high of $23.25.
The release of these earnings results highlights the ongoing challenges faced by BioStem Technologies in the current market environment. Investors will likely be looking closely at the company’s future strategies and potential for recovery. Further analysis and updates on BioStem Technologies can be accessed through various financial news platforms.
